Benitec Biopharma
BNTC
#7818
Rank
$86.36 M
Marketcap
$9.22
Share price
-4.46%
Change (1 day)
4,290.48%
Change (1 year)

P/E ratio for Benitec Biopharma (BNTC)

P/E ratio as of July 2024 (TTM): -0.3761

According to Benitec Biopharma 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.376065. At the end of 2022 the company had a P/E ratio of -0.0059.

P/E ratio history for Benitec Biopharma from 2016 to 2017

PE ratio at the end of each year

Year P/E ratio Change
2022-0.0059-90.33%
2021-0.0612174.14%
2020-0.0223

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
19.8-5,371.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.33 786.37% Bahamas

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.